Denali Advisors’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $542K | Buy |
8,310
+500
| +6% | +$36.6K | 0.06% | 231 |
|
|
2025
Q4 | $629K | Buy |
7,810
+1,900
| +32% | +$153K | 0.07% | 231 |
|
|
2025
Q3 | $485K | Hold |
5,910
| – | – | 0.05% | 231 |
|
|
2025
Q2 | $539K | Buy |
5,910
+100
| +2% | +$8.94K | 0.06% | 215 |
|
|
2025
Q1 | $532K | Buy |
5,810
+200
| +4% | +$17.5K | 0.06% | 227 |
|
|
2024
Q4 | $478K | Sell |
5,610
-2,508
| -31% | -$220K | 0.05% | 241 |
|
|
2024
Q3 | $710K | Buy |
8,118
+507
| +7% | +$42.7K | 0.08% | 211 |
|
|
2024
Q2 | $601K | Buy |
7,611
+700
| +10% | +$57.5K | 0.16% | 124 |
|
|
2024
Q1 | $625K | Sell |
6,911
-298
| -4% | -$27.2K | 0.18% | 122 |
|
|
2023
Q4 | $634K | Buy |
7,209
+100
| +1% | +$8.33K | 0.19% | 116 |
|
|
2023
Q3 | $601K | Buy |
7,109
+500
| +8% | +$45.2K | 0.21% | 118 |
|
|
2023
Q2 | $653K | Sell |
6,609
-300
| -4% | -$28.2K | 0.23% | 112 |
|
|
2023
Q1 | $663K | Buy |
6,909
+109
| +2% | +$10.1K | 0.28% | 89 |
|
|
2022
Q4 | $618K | Sell |
6,800
-800
| -11% | -$68K | 0.26% | 97 |
|
|
2022
Q3 | $604K | Buy |
7,600
+100
| +1% | +$8.47K | 0.29% | 88 |
|
|
2022
Q2 | $625K | Buy |
7,500
+6,700
| +838% | +$552K | 0.27% | 90 |
|
|
2022
Q1 | $66K | Buy |
800
+200
| +33% | +$15.7K | 0.03% | 222 |
|
|
2021
Q4 | $45K | Buy |
600
+100
| +20% | +$7.51K | 0.02% | 260 |
|
|
2021
Q3 | $38K | Buy |
500
+100
| +25% | +$7.74K | 0.02% | 189 |
|
|
2021
Q2 | $31K | Sell |
400
-10,200
| -96% | -$788K | 0.01% | 192 |
|
|
2021
Q1 | $744K | Sell |
10,600
-25,200
| -70% | -$1.9M | 0.23% | 128 |
|
|
2020
Q4 | $2.54M | Sell |
35,800
-12,800
| -26% | -$804K | 0.43% | 85 |
|
|
2020
Q3 | $2.79M | Sell |
48,600
-9,500
| -16% | -$568K | 0.55% | 62 |
|
|
2020
Q2 | $3.54M | Sell |
58,100
-90,500
| -61% | -$5.59M | 0.69% | 43 |
|
|
2020
Q1 | $8.17M | Sell |
148,600
-22,700
| -13% | -$1.52M | 1.78% | 4 |
|
|
2019
Q4 | $12.4M | Buy |
171,300
+72,600
| +74% | +$4.94M | 1.75% | 6 |
|
|
2019
Q3 | $6.53M | Sell |
98,700
-3,100
| -3% | -$199K | 0.91% | 40 |
|
|
2019
Q2 | $6.32M | Buy |
101,800
+50,900
| +100% | +$2.94M | 0.95% | 44 |
|
|
2019
Q1 | $2.75M | Sell |
50,900
-5,500
| -10% | -$309K | 0.44% | 60 |
|
|
2018
Q4 | $3.3M | Buy |
+56,400
| New | +$3.54M | 0.55% | 52 |
|
|
2017
Q3 | – | Sell |
-13,300
| Closed | -$857K | – | 273 |
|
|
2017
Q2 | $857K | Sell |
13,300
-28,100
| -68% | -$1.77M | 0.14% | 94 |
|
|
2017
Q1 | $2.52M | Sell |
41,400
-67,940
| -62% | -$4.08M | 0.37% | 71 |
|
|
2016
Q4 | $6.37M | Sell |
109,340
-32,700
| -23% | -$1.93M | 1.11% | 38 |
|
|
2016
Q3 | $8.22M | Buy |
142,040
+17,540
| +14% | +$1.03M | 1.25% | 28 |
|
|
2016
Q2 | $7.19M | Buy |
124,500
+23,700
| +24% | +$1.36M | 1.24% | 29 |
|
|
2016
Q1 | $6.09M | Sell |
100,800
-10,900
| -10% | -$610K | 1.33% | 25 |
|
|
2015
Q4 | $6.09M | Buy |
111,700
+14,300
| +15% | +$820K | 1.36% | 26 |
|
|
2015
Q3 | $5.54M | Buy |
97,400
+500
| +0.5% | +$28.6K | 1.28% | 28 |
|
|
2015
Q2 | $5.29M | Buy |
96,900
+38,500
| +66% | +$2.12M | 1.15% | 30 |
|
|
2015
Q1 | $3.18M | Buy |
58,400
+51,500
| +746% | +$2.6M | 0.73% | 53 |
|
|
2014
Q4 | $322K | Buy |
6,900
+6,100
| +763% | +$286K | 0.09% | 102 |
|
|
2014
Q3 | $37K | Hold |
800
| – | – | 0.01% | 110 |
|
|
2014
Q2 | $37K | Sell |
800
-1,800
| -69% | -$84.8K | 0.01% | 130 |
|
|
2014
Q1 | $121K | Buy |
+2,600
| New | +$114K | 0.03% | 129 |
|
Other funds holding DOX
BGC
BIP
VPM
Denali Advisors's DOX Position: Q1 2026 in Review
Denali Advisors increased its Amdocs (DOX) stake by 6.4% in Q1 2026, buying an estimated $36.6K and bringing the position to 8,310 shares worth $542K. The position accounts for 0.06% of the portfolio, ranked #231.
Denali Advisors first reported a position in DOX in Q1 2014 and has held it in 44 quarters since. The position peaked at $12.4M in Q4 2019. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.
- Denali Advisors held 8,310 shares of Amdocs worth $542K as of Q1 2026.
- Denali Advisors bought 500 Amdocs shares in Q1 2026, an estimated $36.6K.
- Amdocs made up 0.06% of Denali Advisors's portfolio in Q1 2026, its #231 holding.
- Denali Advisors first reported a position in Amdocs in Q1 2014 and has held it in 44 quarters since.
- Denali Advisors's Amdocs position peaked at $12.4M in Q4 2019.
- 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.
Based on Denali Advisors's 13F filing for Q1 2026, filed 8 May 2026.